Qsemble Capital Management LP Makes New Investment in Agilent Technologies, Inc. $A

Qsemble Capital Management LP purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 84,958 shares of the medical research company’s stock, valued at approximately $11,560,000. Agilent Technologies makes up 1.0% of Qsemble Capital Management LP’s holdings, making the stock its 11th largest holding.

Several other hedge funds also recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA increased its position in Agilent Technologies by 13.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after buying an additional 1,713,216 shares in the last quarter. Wellington Management Group LLP increased its position in Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after buying an additional 433,342 shares in the last quarter. Generation Investment Management LLP increased its position in Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after buying an additional 582,093 shares in the last quarter. Ameriprise Financial Inc. increased its position in Agilent Technologies by 15.1% during the third quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock worth $347,685,000 after buying an additional 354,480 shares in the last quarter. Finally, Troy Asset Management Ltd increased its position in Agilent Technologies by 0.3% during the third quarter. Troy Asset Management Ltd now owns 2,404,161 shares of the medical research company’s stock worth $308,574,000 after buying an additional 6,341 shares in the last quarter.

Analysts Set New Price Targets

Several research firms have weighed in on A. HSBC began coverage on Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target for the company. UBS Group dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Wells Fargo & Company lowered their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Morgan Stanley lowered their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Finally, Wall Street Zen downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Agilent Technologies presently has an average rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $111.69 on Friday. The company has a market cap of $31.56 billion, a P/E ratio of 24.66, a P/E/G ratio of 2.38 and a beta of 1.22. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 52 week low of $107.07 and a 52 week high of $160.27. The business has a fifty day simple moving average of $115.06 and a 200-day simple moving average of $130.68.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.